Press

Tacalyx, a biotech company focused on the discovery and development of novel anti-TACA (Tumor Associated Carbohydrate Antigens) cancer therapies, today announced that it has successfully secured €7 million in seed funding. The funding round involves a syndicate of leading European life science and technology investors co-led by Boehringer Ingelheim Venture Fund and Kurma Partners and joined by Idinvest Partners, High-Tech Gründerfonds (HTGF), coparion, and Creathor Ventures. Tacalyx, a spin-

Digital⁺ Partners Leads New Funding Round in Growing Automated Malware Analysis & Detection Provider to Combat Latest Advanced Threats and Support Market Expansion VMRay, a provider of automated malware analysis and detection solutions, today announced that it has closed its series B round of funding in the amount of $10 million (€9 million) led by Digital⁺ Partners, one of the leading technology growth equity firms in Europe, and supplemented eCAPITAL, an early investor. This brings

Belyntic, a Berlin-based chemistry-for-healthcare startup and developer of the Peptide Easy Clean (PEC) purification technology, has completed its seed financing round amounting to €1.3 million. The funding is led by the Investitionsbank Berlin (IBB), with the High-Tech Gründerfonds (HTGF) also climbing on board alongside business angel Till Knorr. Belyntic's potential in the field of peptide therapeutics was immediately recognized by major industry insiders after its foundation in May 2018.

Bitwala, the only crypto-first banking service in the European Economic Area, raises 13 million Euro in Series A funding round to accelerate growth and offer B2B accounts Global Brain and Sony Financial Ventures’ jointly invest in Bitwala as partners for Bitwala’s global expansion NKB Group, the UK-based investment and advisory firm focused on blockchain technology, is expanding its European portfolio with Bitwala Earlybird and coparion, two existing investors, contribute half of th

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced that the German Federal Ministry of Education and Research has awarded its subsidiary, Immunic AG, a grant in the amount of up to EUR 653,535 (approximately USD 730,000) in support of the InnoMuNiCH (Innovations through Munich-Nippon Cooperation in Healthcare) project. The InnoMu

Europe's leading online optician has completed a 65 million euro financing round. The Büll Family Office led the equity round with participation from existing investors (e.g. Grazia Equity, Stephan Schambach und Ehssan Dariani), while Global Growth Capital provided a senior debt facility. The company enjoyed strong growth and profitability in 2018, and the investment will enable the company to accelerate this strong momentum with further development of its retail store portfolio and acceleratio

The shareholders of Cytena GmbH ("Cytena") have agreed to sell all Cytena shares to CELLINK AB ("CELLINK") for a purchase price of 30.25M euros ("acquisition"). Through CELLINK’s complimentary technology offering cytena sees great synergies that will support and accelerate future growth of Cytena. An extended product offering and a stronger global presence are just some of the benefits for our Cytena’s customers and partners. Background and motivation for the acquisition Through this strat

Twelve project teams presented their top-class research to 19 investors, four pharmaceutical companies, one family office and one industry partner The High-Tech Gründerfonds (HTGF) and the Innovation and Start-up Center Biotechnology (IZB) in Martinsried near Munich organized together with Bayer AG and Boehringer Ingelheim as strategic partners, the "5th Munich Life Science Pitch Day" held on July 11, 2019 at the Faculty Club of the IZB. 29 project teams applied for the Pitch Day and 12 select

The life science start-up Pantherna Therapeutics secures €3.5 million in a successful seed-financing round. The start-up presents a proprietary, innovative technology platform for the development of novel mRNA therapeutics to treat Acute Respiratory Distress Syndrome (ARDS), a severe lung disease. The funds will be used to advance R&D activities and hire additional scientific staff. Investors are the High-Tech Gründerfonds (HTGF), European Business Angel Prof. Detlev Riesner

MoBerries, headquartered in Berlin, closes a seven-figure funding round from the Abu Issa Investment Group, HTGF, 42CAP, LITTLEROCK and other renowned business angels. MoBerries continues to develop & expand in Germany, solving the inefficiencies in the HR market with the AI-based automated preselection of applicants.   MoBerries builds technology which connects actively seeking candidates to companies by leveraging an AI-based matching engine. The engine adapts the sourcin

Simreka, simulation software that accelerates materials driven product and manufacturing process innovation using AI, today announced that it has raised a seven figure seed financing round led by High-Tech Gruenderfonds (HTGF) with participation from the SAP.iO Fund. Simreka has built a powerful enterprise simulation software and data service that empowers brands and manufacturers to accelerate their R&D cycles and significantly reduce their time-to-market with products that meet evolving cu

HTGF wins the founders of the former start-up FOND OF as investors for the HTGF III HTGF III was reopened for the entry of the FOND OF founders FOND OF founders participate with 3 million euros HTGF joins FOND OF's new Growth Accelerator xdeck   On the occasion of last year's Family Day, the HTGF announced the second closing of Fund III with a record volume of EUR 316.5 million. This fund has now been reopened to enable the entry of the founders of the successful Cologne

Deep learning and AI have revolutionized how images, sounds and natural language are processed. However, software for Computer-Aided Design (CAD) for the development of technical products is still using traditional techniques. Neural Concept Shape is the first deep learning software solution dedicated to Computer Assisted Engineering and Design. The cloud-based simulation software allows clients to speed up development cycles, enhance product performance and reduce computational costs. Market

As a seed investor, the HTGF invests very early in new technologies, innovations and markets, with the clear goal of bringing market-leading companies along with it. "As Quentic's first institutional investor, we are very excited about the renewed commitment of these two strong partners. It underlines the great potential of the company. The Quentic team has done an outstanding job in the past years and has set the course for the European market leadership in the field of HSE and CSR software", e

Quantum technologies have the potential to propel computer and communication systems to a new level, paving the way for the next major tech revolution. For this to become a reality, however, extremely low operating temperatures verging on absolute zero (–273°C) are required. Industrial-scale implementation had previously been hindered by the absence of a scalable cooling solution – and this is exactly what kiutra is developing. The deep-tech startup is the first company worldwide that is ab